Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type (Endovascular Coiling, Flow Diverters, Surgical Clipping, Others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Intracranial Aneurysm Market Size

The global intracranial aneurysm market size was valued at USD 2.57 billion in 2025 and is projected to grow from USD 2.83 billion in 2026 to USD 6.13 billion by 2034, registering a CAGR of 10.14% during the forecast period from 2026 to 2034. North America dominated the intracranial aneurysm market with a market share of 39.45% in 2025.

An intracranial aneurysm is a weakened, balloon-like bulge in a blood vessel within the brain, which can pose a serious health risk if it ruptures. This condition occurs when the arterial wall becomes thin due to factors such as high blood pressure, smoking, genetic predisposition, or head trauma. While many aneurysms remain asymptomatic, larger ones may cause headaches, vision disturbances, or neurological deficits due to pressure on surrounding brain tissues.

Aneurysm rupture can lead to a life-threatening subarachnoid hemorrhage, causing sudden severe headaches, nausea, loss of consciousness, and neurological impairment. Diagnosis typically involves imaging techniques like CT angiography, MRI, or cerebral angiography. Treatment options include surgical clipping and minimally invasive endovascular coiling, both aimed at preventing rupture and improving patient outcomes.

The intracranial aneurysm market is experiencing significant growth, driven by technological innovations, increasing demand for minimally invasive treatments, and rising awareness about the importance of early diagnosis and intervention. The growing prevalence of intracranial aneurysms is a key driver in the market.

• For instance, in May 2023, according to the National Library of Medicine, the prevalence of unruptured intracranial aneurysms reached as high as 3% in the general population.

As the use of cross-sectional imaging modalities such as CT and MRI imaging expands in clinical practice, the detection of intracranial aneurysms has become increasingly more frequent, contributing to early diagnosis and intervention in the market. Moreover, emerging economies, particularly in the Asia-Pacific region, offer untapped growth opportunities as healthcare infrastructure improves, advanced treatments become more accessible, and neurovascular research accelerates.

Type Analysis

Endovascular coiling holds the largest market share in the global market, primarily due to its minimally invasive nature, faster recovery times, and lower risk of complications compared to traditional surgical methods. This procedure involves inserting soft platinum coils into the aneurysm through a catheter, promoting clot formation and reducing rupture risks. Unlike surgical clipping, coiling eliminates the need for a craniotomy, minimizing patient trauma and hospital stays. The growing preference for less invasive procedures, coupled with advancements in coil design and imaging technologies, continues to drive the dominance of endovascular coiling.

Request Customizationto receive a tailored report.

End-User Analysis

Hospitals and clinics dominate the market due to their well-equipped infrastructure, access to specialized neurosurgeons, and availability of advanced medical technologies such as angiography systems, flow diverters, and embolization coils. These facilities handle a high volume of both emergency and elective aneurysm cases, ensuring timely diagnosis, treatment, and post-operative care. As healthcare institutions increasingly invest in cutting-edge neurovascular treatment solutions, hospitals and clinics remain the preferred choice for intracranial aneurysm management, further strengthening their position as the leading end-users in this market.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the dominant position in the global market, driven by the widespread adoption of neurovascular treatments and the strong presence of key industry players such as Medtronic plc, Stryker Corporation, and Johnson & Johnson. The region benefits from rising healthcare expenditures, well-established reimbursement policies, and increasing cases of intracranial aneurysms, prompting greater demand for advanced treatment options.

Moreover, continuous research and development efforts, along with frequent FDA approvals for innovative medical devices, further solidify North America's leadership. The growing emphasis on early diagnosis, coupled with cutting-edge healthcare infrastructure, ensures sustained market growth in this region.

U.s. Intracranial Aneurysm Market Trends

• The U.S. dominates the intracranial aneurysm industry due to high R&D investments and the launch of innovative products by key players. In June 2024, MicroVention, Inc., a subsidiary of Terumo Corporation, commercially launched the LVIS EVO intraluminal support device for treating wide-neck intracranial aneurysms. Continuous technological advancements, favorable reimbursement policies, and a strong healthcare infrastructure further strengthen the country’s leadership.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Intracranial Aneurysm Market Trends

Asia-Pacific is projected to register the highest CAGR in the global market. This rapid growth is fueled by increasing healthcare investments, a rising prevalence of intracranial aneurysms, and a growing preference for minimally invasive neurovascular procedures. Countries such as China, India, and Japan are witnessing improvements in healthcare infrastructure and expanding access to advanced treatment modalities. Moreover, rising awareness about early aneurysm diagnosis and government initiatives to enhance neurovascular care are accelerating market expansion.

• India's market for intracranial aneurysm is experiencing rapid growth due to the introduction of innovative products by key players. In June 2022, Medtronic launched the Pipeline Vantage Embolization Device with Shield Technology, enhancing treatment options for brain aneurysms. Rising healthcare investments, increasing awareness, and improvements in healthcare accessibility are further driving market expansion, making India a crucial emerging market in this sector.
• China’s intracranial aneurysm industry is growing due to increasing healthcare investments, a rising prevalence of cerebrovascular diseases, and the adoption of minimally invasive neurovascular procedures. The expansion of healthcare infrastructure and government support for neurovascular research are boosting market demand. As advanced treatment options become more accessible, China is emerging as a significant player in the market.
• Japan is experiencing substantial growth in the market, driven by advancements in neurovascular technologies and the increasing adoption of minimally invasive treatments. A well-established healthcare system, strong government support for medical innovation, and heightened awareness of early aneurysm detection further contribute to market expansion. Japan’s emphasis on high-quality healthcare solutions makes it a key market for neurovascular treatments.

Europe Market Trends

• Germany is one of Europe’s largest markets for intracranial aneurysm treatments, driven by advanced treatment options and the expansion of key players. In January 2024, Evasc Neurovascular announced new strategic growth initiatives, establishing Evasc Neurovascular GmbH in Germany to strengthen its European operations. The country’s robust healthcare infrastructure, increasing adoption of innovative neurovascular devices, and growing research initiatives continue to drive market expansion.
• Canada’s intracranial aneurysm industry is expanding due to the introduction of advanced neurovascular devices. In June 2023, Fluid Biomed Inc. launched REDIRECT, its first-in-human clinical trial for the ReSolv hybrid polymer-metal flow-diverting stent, demonstrating successful implantation with no adverse effects. The country's supportive regulatory environment, rising adoption of minimally invasive treatments, and growing investments in neurovascular research contribute to sustained market growth.
• The UK is witnessing steady market growth driven by the adoption of advanced neurovascular devices, rising aneurysm prevalence, and an expanding healthcare infrastructure. Increased demand for minimally invasive procedures and favorable regulatory approvals further support market expansion. With a strong focus on early diagnosis and treatment advancements, the UK continues to play a key role in the European intracranial aneurysm industry.

List of Key and Emerging Players in Intracranial Aneurysm Market